KEYNOTE PRESENTER: Barry Eisenstein Senior VP, Scientific Affairs Clinical Professor of Medicine Cubist Pharmaceuticals Harvard Medical School
	FEATURED PRESENTERS:   Sharath Hegde, Ph.D. Vice President Pharmacology Theravance, Inc. Rita Helfand Associate Director Epidemiologic Sciences CDC Stanley Deresinski Clinical Professor Medicine - Med/Infectious Diseases Stanford University
	DISTINGUISHED SPEAKERS: Mark Alfenito Head of Technology Licensing KaloBios Pharmaceuticals, Inc Jon B. Bruss, M.D. Chief Medical Officer Achaogen, Inc. Danielle Drayton, Ph.D. Therapeutic Area Director Infectious Diseases Decision Resources Mike Dudley Senior Vice President Research and Development MPEX Pharmaceuticals Jacques Dumas Associate Director Infection Chemistry AstraZeneca Roger Echols Consultant Infectious Disease Drug Development Consulting ID3C Francois Franceschi Sr. Director of Ribosome Targeting and Technology Rib-X Pharmaceuticals, Inc. Nafsika Georgopapadakou, Ph.D. Vice President, Research NovaBay Pharmaceuticals Barry Hafkin Chief Medical Officer Affinium Pharmaceuticals Andrew Kielbania Chief Scientist BioNeutral Laboratories Anil Koul, Ph.D. Department of Antimicrobial Research Tibotec, Johnson and Johnson	Andrew MacPherson President and Co-Founder Diagnostics Intelligence Group, Inc. Bruce A. Maguire, Ph.D. Principal Scientist Pfizer Inc. Bindu Murthy, Pharm.D. Associate Director, Discovery Medicine and Clinical Pharmacology Bristol-Myers Squibb Malcolm Page Head, Discovery Biology Basilea Pharmaceutica International Ltd. Thomas Parr, Ph.D. Chief Scientific Officer Targanta Gary Patou Executive Partner MPM Capital John P. Quinn Senior Advisor, Antibacterials Pfizer Adam R. Renslo, Ph.D. Associate Director Small Molecule Discovery Center University of California, San Francisco Carole Sable Chief Medical Officer Novexel SA Pedro Serrano Research Associate Department of Molecular Biology The Scripps Research Institute Annie Wong-Beringer, PharmD, FCCP Associate Professor and Vice Chair Clinical Pharmacy and Pharmaceutical Economics & Policy University of Southern California
	Special Thanks to our Advisory Board:   Karen Bush, Johnson & Johnson Roger Echols, Replidyne Ann Ginsberg, Global Alliance for TB John Hollway, Achaogen Charles James, UCSD Jennifer Leeds, Novartis   Malcolm Page, Basilea Pharmaceutica Sameeh Salama, NAEJA Pharmaceutical John Shiver, Merck Lynn L. Silver, LL Silver Consulting Glenn Tillotson, Viropharma